PhD (Specialist in Genetic Toxicology; Univ. Autónoma de Barcelona) and Bachelor of Pharmacy (Univ. Central de las Villas, Cuba). Current position: Senior Toxicologist & Nonclinical Safety Adviser, at Ferrer Advanced Biotherapeutics. Ferrer Internacional. Previous positions: Pharmacovigilance Officer/Senior Nonclinical Toxicologist (Ferrer); Medical Adviser. Dermatology Area (Ferrer); Senior Toxicologist. Head of In vivo Toxicology Group (Ferrer); Senior Nonclinical Toxicology Study Director (RCC-CIDA s.a.l.). Senior Toxicologist/Nonclinical Safety with more than 15 years of experience working in the design and management of several fields of nonclinical toxicology and safety issues to support the efficacy/safety in the R&D in New Development Projects with the aim to obtain new medicinal products. Co-author of over 12 peer-review of scientific publications. Invited Speaker at 20 Scientific Events in the last 10 years at international congress. Expert of European Commission: Sixth and Seven Framework Programme. Area Preclinical Toxicology and Mutagenesis. Expert Member Panel in Innovative Medicines Initiative (IMI)-Scientific Panel to evaluate the proposals for the IMI2 9th Call: topic on ‘Next generation of electronic translational safety–NexGETS. Member of Editorial Board of scientific journals and several Organizing Committee of Scientific Congress. Member of Jury several doctoral theses (Univ. Autónoma de Barcelona. Current interests: Open innovation & Collaborative Bio-Research. Advanced Therapies. Neuropharmacology. Ophthalmology. Molecular diagnostics and other Therapeutic areas.
Senior Toxicologist & Nonclinical Safety Adviser
Academician Victor S. Dorodny is the Founder and Chief Scientist of the Naturopathic Evidence-based Wellness (NEW™) Institute in Malibu, California. Prof. Dorodny is dedicated to education of wellness consumers, and implementation his principles of complementary convergence of Naturopathy and traditional Medical Science to achieve and maintain Natural Health. He is the former Chief Medical Officer of the Malibu Medical Reserve Corpse (MMRC)—a volunteer organization under the guidance of the US Surgeon General dedicated to assisting authorities in a form of Medical Disaster Assistance Teams. (MDAT) He is the past Vice-President, of ICN Eastern Europe, a Division of ICN Pharmaceuticals, Inc, Costa Mesa-based global pharmaceutical company and has many years of experience in pharmaceutical, vitamins and nutraceutical manufacturing. As practicing/consulting physician, academician and technologist with 30 years of clinical and consulting experience he is an expert on Anesthesiology and Pain Management, Rehabilitation, and Multi-disciplinary approach to the management of chronic disease states. Academicia Dorodny’s areas of expertise encompass traditional medical practice and naturopathy with a focus on nutrition, botanical medicine, homeopathy, hydrotherapy, physical manipulation, pharmacology and psychology. Dorodny was founder and president of Health PRO Worldwide, Inc., a Health & Wellness consulting company in Pasadena, California since 1993. Since 1995 he is the Founder & Chairman of TRIPAC, National Health & Wellness Advocacy dedicated to ongoing transformation of health consumers and provider of health & wellness products and services, and team approach to utilization of traditional medicine and naturopathic strategies for optimal health. He has served as consultant to the Economic and Social Council of the United Nations; Technical Advisor to the United States Department of Justice and FBI; past president of the National Association of Managed Care Physicians (NAMCP). He is a Board Member of Association of Medical Directors of Information Systems (AMDIS); Board member of the IPA Association of America (TIPAAA), National Managed Health Care Congress/Health Information Technologies (NMHCC/HIT); California State Pharmacy Partnership; Health Care Advisory Committee-Assembly; California Legislature and US Congress. Member(A) of the Scientific Advisory Board of the US Food and Drug Administration (US FDA). A native of Odessa, USSR Prof. Dorodny received his M.D. and M.P.H. degrees from N.I. Pirogov Medical Institute in Odessa, USSR in 1975; He completed his residency in Anesthesiology at the USC-Los Angeles County Medical Center in 1982. Graduate USC Executive Management Institute in Health Care in 1993 and received Ph.D. in Health Informatics from International Informatization Academy in 1997. Prof. Dorodny is Board Certified by the American Academy of Pain Management, and is an Associate in Medicine of the American College of Legal Medicine (ACLM). Prof. Dorodny has made significant contributions to major mass media publications, peer review journals and trade publications. He has authored numerous monographs and books, and his editorial board appointments include Managed Healthcare, and The Medical Reporter. He is the only physician in the USA on the editorial boards of US Pharmacist and Information Security Journal. He is a frequently invited keynote presenter at national and international conferences, and featured guest on national TV and radio. Prof. Dorodny is an Active Academician with the International Informatization Academy (IIA) and a frequent participant in projects at the Institute for Alternative Futures, National Association of Consulting Pharmacist, and Joint Commission for Accreditation of Hospital Organizations (JCAHO), National Pharmaceutical Council, and US Food and Drug Administration.
Naturopathy and traditional Medical Science
Dr. Barkat Ali Khan: Was born on 20 September 1982 in, Bannu, Khyber Pakhtunkhwa, Pakistan. He completed his B. Pharm. in 2005 from Gomal University D.I Khan, M. Phil. and PhD (Pharmaceutics) in 2010 and 2013 respectively from the Islamia University of Bahawalpur under the supervision of renowned professor Dr. Navid Akhtar. He is serving as associate Professor in the department of Pharmaceutics at faculty of Pharmacy, Gomal University D.I Khan, Pakistan, since January 2012. He also served the school of pharmacy, Kampala international university Uganda; east Africa for one year. He has more than 150 publications in national and international journals. He is the editor and associate editor of many Journals. He is serving as Editorial Board Member and reviewer for many reputed journals. He received scholarship for his master and PhD studies from the higher education commission (HEC) of Pakistan. He was granted travel expenses to present his research papers at Thailand, Sweden and Turkey by HEC.
Health Information Management, Medical and Health Sciences
Dr. Niranjan Koirala received his Ph.D. in Biochemistry (2016) from Sun Moon University, Republic of Korea and Postdoctoral Research Training at the Instituto de Investigaciones Biomedicas from the Universidad Nacional Autonoma de Mexico, Mexico (2017-18). He has been awarded with the best poster and oral presentations at the international conferences and with Nepal Bidhya Bhushan “A” medal from the honorable President of Nepal, Dean’s Choice award by Sun Moon University, South Korea, BRICPL Young Scientist award by Biologix Research and Innovation Center, India to name a few selected ones. He is a member of American Society for Microbiology (ASM) and International Chemical Biology Society and a lifetime member of Biotechnology Society of Nepal. Along with research, he also has experiences in supervising and mentoring undergraduate and graduate students. He is serving as a peer reviewer in several international journals from Springer and MDPI. He has published more than 15 research articles in reputed indexed journals reaching more than 350 citations according to Google scholar citations and has published 4 patents issued by the Korean Intellectual Patents Office. He is currently working as a post-doctoral fellow with Prof. Hojae Shim at the Environmental Biotechnology Laboratory, University of Macau.
Industrial biotechnology, Bio-based energy, Biogas/Biodiesel production, Resources recovery from wastewater treatment, Natural products, Biochemical engineering, and Strain engineering for over productions.
Dr. Fuhr has 30+ years of experience in teaching and research. He is Professor of Economics at Widener University. Dr. Fuhr’s primary research areas are antitrust, health economics, pharmacoeconomics, telecommunications, and sports economics. He has published over forty journal articles. In health care, he has written on hospital mergers, exclusive arrangements, health insurance, bundling and doctor’s fees. In pharmacoeconomics, Dr. Fuhr has written on cost benefit analysis and predictive modeling. Dr. Fuhr’s primary research areas are antitrust, health economics, pharmacoeconomics, telecommunications, and sports economics.
antitrust, health economics, pharmacoeconomics, telecommunications, and sports economics.
Name: Donatas Stakišaitis Address: National Cancer Institute, Santariški? 1, LT-08660 Vilnius, Lithuania E-mail : firstname.lastname@example.org Date of birth: February 24, 1956 Citizenship: Lithuanian Academic qualification: Kaunas Medical University Academic period: 1974–1981 Speciality: physician Employment history - 1981–1985, physician of Regional Central Hospital. - 1985–1988, a post-graduate course at the Post-graduate Medical Department of Vilnius University; also, part-time physician at the Department of Intensive Care (thesis defended for the Ph.D. degree in 1988). - 1988–1992, engaged in research at the Institute of Cardiology, Kaunas Medical University; prepared and defended a thesis (dissertation) for Habil.D. of medicine degree in 1992. - 1992–1994, a researcher at Vilnius University Emergency Hospital; also, a part-time physician at the Department of Anaesthesiology and Intensive Care; - 1994–1996, a research associate at the Department of Medicine of the University of Illinois, Chicago; - 1996–1998, a research associate at the Northwestern University, Chicago (studies performed at this department were selected for an award by Central Society for Clinical Research (09 25 97, Chicago); - 1998–2002, a researcher of Paediatric Center at Vilnius University Medical Faculty; - from 1999 expert at Preclinical and Clinical Trial Division of the State Medicines Control Agency of Lithuania; from 2001 to 2012 – head of Preclinical and Clinical Trial Division of the State Medicines Control Agency of Lithuania (assessing applications and protocols for clinical trials of investigational medicinal products: non-clinical and clinical parts); - from 2002 – researcher of Oncology Institute at Vilnius University; from 2015 – Head researcher. - 2005–2017 Professor at the Mykolas Romeris University, Department of Biolaw, Vilnius. - From 2016 Professor at the Lithuanian University of Health Science, Department of Histology and Embryology
Cardiology, Pharmacology, Drug Development, Clinical Trails, Stem Cell Technology, Genomics.